Key Takeaways
Sclerotherapy consent forms document informed patient consent, contraindication screening, and risk disclosures – essential for legal protection and regulatory compliance in aesthetic and vascular clinics.
A comprehensive template covers patient medical history, pre-procedure instructions, sclerosant agent details, potential side effects (hyperpigmentation, matting, DVT risk), compression stocking guidance, and activity restrictions.
Consent forms must be reviewed by local legal/compliance counsel before use, as template sufficiency varies by jurisdiction (HIPAA in the US, GDPR/CQC in the UK, local equivalents elsewhere).
Pabau’s digital forms platform enables clinics to deliver sclerotherapy consent forms electronically, collect electronic signatures, store HIPAA-compliant records, and automate post-procedure reminders – all in one system.
Download your free sclerotherapy consent form template
Sclerotherapy consent form template
A ready-to-use consent form covering patient details, contraindication screening, risk disclosures, informed consent statements, PAH warnings, photography consent, and medical director sign-off.
Download templateSclerotherapy is a minimally invasive procedure that treats varicose veins and spider veins by injecting a sclerosant solution directly into affected vessels. Practices performing this procedure must obtain documented informed consent before treatment. A comprehensive sclerotherapy procedure guide and a clinical documentation template protect both the patient and your practice by confirming understanding of the procedure, risks, benefits, and post-care responsibilities.
What is a sclerotherapy consent form?
A sclerotherapy consent form is a legal and clinical document that confirms a patient has received information about the procedure, understands the risks and benefits, and consents to treatment. The form documents the patient’s medical and surgical history, identifies contraindications (such as pregnancy or active infection), discloses potential side effects, explains post-procedure care expectations, and obtains signatures from both the patient and the treating practitioner or medical director.
Beyond legal protection, consent forms are a cornerstone of clinical governance. In the UK, the Care Quality Commission (CQC) requires documented evidence of informed consent for all invasive procedures. In the US, state medical practice acts and medical board regulations govern informed consent requirements. HIPAA separately mandates that practices maintain secure, private patient records, including any consent documentation collected. Consent forms also demonstrate your practice’s commitment to patient safety and regulatory compliance during audits or investigations.
How to use this sclerotherapy consent form template
This template is structured for practice workflow and includes five operational steps:
- Patient information & medical history – Collect full name, date of birth, contact details, and a comprehensive medical history including medications, allergies, previous vein treatments, and pregnancy status. This section identifies absolute contraindications (e.g. pregnancy, active DVT) and relative contraindications requiring specialist assessment.
- Procedure and sclerosant disclosure – Document which sclerosant agent will be used (e.g. polidocanol/Asclera, sodium tetradecyl sulfate/STS, hypertonic saline) and confirm the patient understands the mechanism of action, expected appearance of the injection site post-procedure, and typical healing timeline.
- Risk and side effect disclosure – Present common side effects (hyperpigmentation, temporary bruising, itching) and serious but rare complications (superficial thrombophlebitis, anaphylaxis, DVT). Frame these as potential outcomes, not guarantees, and confirm the patient acknowledges understanding.
- Pre- and post-procedure care instructions – State that compression stockings are typically worn post-procedure. Encourage walking immediately after treatment, and advise patients to avoid strenuous exercise for a defined period (typically 5-7 days). Confirm the patient will follow aftercare guidance and report any unusual symptoms.
- Signature and medical director attestation – Obtain signatures from the patient (and a parent/guardian if under 18), the treating practitioner, and the medical director where your jurisdiction requires it. Include the date and time. Add a statement confirming the practitioner discussed risks verbally and the patient had the opportunity to ask questions.
Many practices use digital consent forms to streamline this workflow. Electronic capture eliminates paper storage, enables AI-assisted clinical documentation to populate standard sections, and automatically archives signed consents in a HIPAA-compliant patient record accessible only to authorized staff.

Who is this sclerotherapy consent form template for?
This template is designed for aesthetic practices, dermatology practices, medical spas, and vascular centers that perform sclerotherapy. It applies to practices in the US (HIPAA), the UK (CQC and GDPR), and other jurisdictions with equivalent informed-consent regulations.
Practices offering skin clinic services, medical spa treatments, and cosmetic vein procedures will find this template immediately usable. For billing guidance on foam-based treatments, see our CCSD Code L8600 guide for unilateral varicose vein injection sclerotherapy. If your practice employs nurse practitioners, physician assistants, or estheticians under a medical director’s supervision, ensure the consent form includes signature lines for the supervising medical director as required by your state or country regulations.
Benefits of a sclerotherapy consent form
Legal and regulatory protection: A signed consent form is your practice’s primary defense against claims that a patient was not informed of risks. It demonstrates adherence to informed-consent standards. State medical practice acts, professional bodies like the American Society for Dermatologic Surgery (ASDS), and — for Medicare/Medicaid-participating facilities — CMS conditions of participation all set these standards. In the UK, consent documentation satisfies CQC expectations and reduces compliance findings during inspections.
Documentation clarity: The form creates a structured, durable record of exactly what information was provided and when. This becomes critical in malpractice defense — documented consent is evidence that the patient was fully informed. Standardized medical documentation also ensures consistency across all practitioners in your practice, reducing variation and improving overall governance.
Patient safety: By requiring patients to review contraindication questions and acknowledge understanding of aftercare, you reduce no-shows for follow-up care and complications from non-compliance. Structured post-care instructions embedded in the consent process improve patient adherence to compression stocking use and activity restrictions – the key drivers of optimal outcomes.
Operational efficiency: Paperless workflows accelerate consent collection during pre-visit check-in. Digital forms reduce data-entry errors, eliminate lost documents, and enable automatic population of standard sections — freeing clinical staff to focus on patient care instead of form administration.
Legal and compliance considerations
This template is provided for educational reference only. Before using it in your practice, have your forms reviewed by local legal counsel and your compliance or risk management team. Template adequacy varies by jurisdiction:
- United States: HIPAA requires documented informed consent; state medical boards may have specific consent language requirements. Verify with your state board of medicine, nursing, or esthetics.
- United Kingdom: The CQC expects detailed informed consent documentation and will review forms during inspections. GDPR compliance means patient data in the form must be encrypted and securely stored with limited access.
- EU countries: GDPR applies; data protection impact assessments may be required. Local medical councils often publish consent form templates aligned to their standards.
- Other jurisdictions: Canada, Australia, and other nations have specific consent frameworks – consult local professional associations (College of Physicians, Nursing Boards, Esthetics Councils) for approved language.
If your practice performs sclerotherapy under a medical director’s supervision (common for nurse practitioners and estheticians), confirm that the consent form includes a medical director signature line consistent with your jurisdiction’s delegation and supervision requirements. Flag any off-label use of sclerosant agents in the consent form and document it in the patient record. For an overview of non-compounded foam sclerotherapy billing, see the CPT Code 36465 guide.
Supporting sclerotherapy documentation
A complete clinical governance system for sclerotherapy includes consent forms, pre-procedure checklists, procedure notes, and aftercare instructions. Beyond the consent form, practices should maintain:
- Pre-procedure checklist: Confirms patient meets candidacy criteria, has reviewed contraindications, has discontinued relevant medications (e.g. anticoagulants) per guidance, and understands pre-appointment fasting/activity restrictions.
- Post-procedure documentation: Records sclerosant agent used, injection sites, volume administered, patient tolerance, and immediate post-procedure observations (vein appearance, patient symptoms).
- Aftercare instructions handout: A patient-facing document (separate from the form) summarizing compression stocking wear duration, activity restrictions, symptom monitoring, and when to contact the practice (e.g. signs of infection, unusual swelling, severe pain).
Electronic patient record systems like Pabau’s client records software store all these documents in a linked, searchable format, with built-in access controls so only authorized team members can view sensitive consent and procedure information. Automated workflows trigger post-procedure email or SMS reminders based on the procedure date, supporting consistent follow-up and better patient outcomes. Clinics using chemical peel treatments alongside sclerotherapy may also benefit from reviewing our chemical peel consent form guide for a comparable consent framework.
Book a demo to see how Pabau’s digital forms, electronic consent capture, and automated post-care reminders streamline your sclerotherapy workflows while keeping all patient records secure and compliant.
Expert resources
Continue your research
Need guidance on clinical record-keeping standards? Safer clinical notes covers documentation best practices that reduce liability and improve patient safety – applicable across all procedures.
Looking to streamline patient intake and consent? Capture forms software enables clinics to deliver digital consent forms, collect signatures, and automatically archive records in a compliant patient portal.
Want to automate post-care reminders? Automated workflows trigger SMS and email reminders based on procedure dates, improving patient compliance with aftercare instructions and compression stocking use.
Frequently asked questions
A sclerotherapy consent form is a legal document confirming that a patient has received information about the procedure, understands the risks and benefits, and agrees to treatment. It documents medical history, contraindications, potential side effects, post-care instructions, and includes signatures from the patient and treating practitioner or medical director.
In most jurisdictions (US, UK, EU, Canada, Australia), documented informed consent is a legal requirement before performing any invasive procedure, including sclerotherapy. Regulatory bodies like the FDA, CQC (UK), and local medical boards mandate consent documentation. Failure to obtain consent creates significant legal liability.
No. While this template provides a comprehensive framework, have your local legal counsel and compliance team review and approve it before use. Consent form requirements vary by jurisdiction, state, and sometimes by individual medical board — customisation is mandatory.
Do not perform the procedure. Documented informed consent is both an ethical and legal requirement. For practices managing multiple consent workflows, a structured consent form approach across service lines reduces administrative risk. If a patient declines to sign, do not proceed – instead, discuss their concerns, answer questions, and offer to reschedule if needed. Document their refusal in the patient record.
The patient must always sign to confirm understanding. The practitioner performing the procedure should also sign to attest that they discussed risks and benefits verbally. If a medical director supervises the practitioner (required in many jurisdictions for nurse practitioners and estheticians), the medical director should also sign to acknowledge supervisory oversight.